Skip to main content
Eczema
resource center
Menu
Menu
Main navigation
Home
Education
Featured Diseases & Conditions
Acute Myeloid Leukemia
Advances in WetAMD/DME
Alzheimer Disease
Chronic Gout
COVID-19
Depression Care 360
Diabetes Technology
Digital Health Solutions in Diabetes
Emergency Medicine
HER2-Positive Early Breast Cancer
HIV Management
HIV Prevention
Psoriatic Arthritis
Uveal Melanoma
Women's Health
Resources
Atlas of Lumps and Bumps
Case Presentations
Commentary
Disease State and Specialty Directory
FDA Alerts
Pearls
Podcasts
Polls
Q&A
Quizzes
Research Summaries
Slideshows
Videos
Featured Conferences
ACR Convergence
AIBD
American Heart Association Scientific Sessions
Consultant360's Practical Updates in Primary Care
Conference on Retroviruses and Opportunistic Infections
Infectious Diseases Society of America’s IDWeek
International AIDS Conference
Society of Hematologic Oncology's Annual Meeting
Clinical Updates
Allergic Asthma
Alzheimer Disease
Endometrial Cancer
Endometriosis
Eosinophilic Disorders
Exocrine Pancreatic Insufficiency
Generalized Pustular Psoriasis
Major Depressive Disorder
Nasal Polyps
Ovarian Cancer
Rheumatoid Arthritis
Schizophrenia
Ulcerative Colitis
Publication
About Consultant
Advertising With Consultant360
Consultant Current Issue
Consultant Archive
Author Guidelines
Consultant Early View
Case Report Templates
FAQ
Job Board
Search
Contact
Login
Menu
Menu
Main navigation
Home
Education
Featured Diseases & Conditions
Acute Myeloid Leukemia
Advances in WetAMD/DME
Alzheimer Disease
Chronic Gout
COVID-19
Depression Care 360
Diabetes Technology
Digital Health Solutions in Diabetes
Emergency Medicine
HER2-Positive Early Breast Cancer
HIV Management
HIV Prevention
Psoriatic Arthritis
Uveal Melanoma
Women's Health
Resources
Atlas of Lumps and Bumps
Case Presentations
Commentary
Disease State and Specialty Directory
FDA Alerts
Pearls
Podcasts
Polls
Q&A
Quizzes
Research Summaries
Slideshows
Videos
Featured Conferences
ACR Convergence
AIBD
American Heart Association Scientific Sessions
Consultant360's Practical Updates in Primary Care
Conference on Retroviruses and Opportunistic Infections
Infectious Diseases Society of America’s IDWeek
International AIDS Conference
Society of Hematologic Oncology's Annual Meeting
Clinical Updates
Allergic Asthma
Alzheimer Disease
Endometrial Cancer
Endometriosis
Eosinophilic Disorders
Exocrine Pancreatic Insufficiency
Generalized Pustular Psoriasis
Major Depressive Disorder
Nasal Polyps
Ovarian Cancer
Rheumatoid Arthritis
Schizophrenia
Ulcerative Colitis
Publication
About Consultant
Advertising With Consultant360
Consultant Current Issue
Consultant Archive
Author Guidelines
Consultant Early View
Case Report Templates
FAQ
Job Board
Advertisement
Eczema
Disease State Hub
News
Research Summaries
Resources
FDA Alerts
From the Journal
FDA Alerts
Eczema
Eczema
FDA: Dupixent Approved for the Treatment of Eczema
03/28/2017
The US Food and Drug Administration has approved Dupixent for the treatment of moderate-to-severe eczema in adults.
03/28/2017
FDA
FDA
FDA Approves New Treatment Option for Eczema
12/22/2016
The FDA has approved a new ointment for the treatment of mild-to-moderate eczema in patients aged 2 years and older.
12/22/2016
Eczema
Eczema
FDA approves Pfizer's eczema ointment
12/15/2016
By Reuters Staff
12/15/2016
FDA
FDA
FDA Approves New Treatment Option for Eczema
12/14/2016
The FDA has approved Eucrisa (crisaborole) ointment for the treatment of mild to moderate eczema (atopic dermatitis) in patients aged 2 years and older.
12/14/2016
advertisement
Advertisement
Advertisement